HYBRID PEPTIDES: A NEW MEDICAL FRONTIER

Chimera sequences represent a significantly developing domain in therapeutic research, presenting a distinct strategy to target previously difficult diseases. Such engineered constructs integrate multiple amino acid motifs, enabling for optimized binding to several sites and potentially overcomin